Assignee
DOUBLE BOND PHARMACEUTICALS AB
SE·3 granted patents·1 pending application·0 citations·filing 2015–2020
Top patents by PatentIndex Score
4 records- 0157US10973772B2Targeted delivery of hydrophilic drugsDOUBLE BOND PHARMACEUTICALS AB·Filed 2018·Granted Apr 13, 2021·0 cites·10 claims
- 0243US10034838B2Targeted delivery of hydrophilic drugsDOUBLE BOND PHARMACEUTICALS AB·Filed 2015·Granted Jul 31, 2018·0 cites·29 claims
- 0340US12458666B2Oral administration of iron succinate for use in treating iron deficiency in patients having heart failureDOUBLE BOND PHARMACEUTICALS AB·Filed 2020·Granted Nov 4, 2025·0 cites·12 claims
- 0439US2021186879A1Targeted delivery of hydrophilic drugs to lungDOUBLE BOND PHARMACEUTICALS AB·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DOUBLE BOND PHARMACEUTICALS AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →